GUTS Overview
Upcoming Projects (GUTS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (GUTS)
-
A Third Opinion: Discussing the potential of Fractyl Health's lead drug candidate Rejuva, an adeno-associated virus (AAV)-based GLP-1 pancreatic gene therapy.
Tickers: GUTS, NVO, LLY
Executed On: Jul 25, 2024 at 11:30 AM EDT -
A Second Opinion: Discussing the potential of Fractyl Health's lead drug candidate Rejuva, an adeno-associated virus (AAV)-based GLP-1 pancreatic gene therapy.
Tickers: GUTS, NVO, LLY
Executed On: Jul 25, 2024 at 08:30 AM EDT -
Sharing your thoughts on the potential of Fractyl Health's lead drug candidate Rejuva, an adeno-associated virus (AAV)-based GLP-1 pancreatic gene therapy.
Tickers: GUTS, NVO, LLY
Executed On: Jul 16, 2024 at 10:00 AM EDT
Upcoming & Overdue Catalysts (GUTS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (GUTS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
